Neuroloxía
Servizo
Universidad Complutense de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (43)
2023
-
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439
-
Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review
International journal of molecular sciences, Vol. 24, Núm. 18
-
Neurotological emergencies: a narrative review
European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 11, pp. 4759-4774
-
Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation
British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration
Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1320-1332
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
2021
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
2020
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
Cytotherapy, Vol. 22, Núm. 1, pp. 1-5
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
-
Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain
Odontology, Vol. 107, Núm. 4, pp. 530-535
-
Use of intravenous brivaracetam in status epilepticus: A multicenter registry
Epilepsia, Vol. 60, Núm. 8, pp. 1593-1601
2018
-
Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice
Stroke, Vol. 49, Núm. 9, pp. 2163-2172
2017
-
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
Scientific Reports, Vol. 7, Núm. 1
-
Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial
Cephalalgia, Vol. 37, Núm. 9, pp. 864-872
2014
-
Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways
Neuroscience, Vol. 268, pp. 48-65
-
Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro
NeuroMolecular Medicine, Vol. 16, Núm. 2, pp. 332-349